Production (Stage)
ACADIA Pharmaceuticals Inc.
ACAD
$21.98
$0.432.00%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 13,484.97% | 469.50% | 186.36% | 127.58% | 98.83% |
| Total Depreciation and Amortization | 24.89% | 186.08% | 179.43% | 259.55% | 450.31% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -256.28% | -263.47% | 35.88% | 18.96% | 7.68% |
| Change in Net Operating Assets | 82.81% | -77.09% | -246.66% | -179.34% | -113.16% |
| Cash from Operations | 133.80% | 844.31% | 319.07% | 334.68% | 214.51% |
| Capital Expenditure | -946.00% | -946.00% | -40.00% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -64.20% | -650.83% | -1,144.34% | -794.35% | -229.83% |
| Cash from Investing | 19.48% | -195.44% | -1,148.40% | -795.58% | -229.87% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -69.08% | -72.76% | -51.62% | 157.69% | 243.23% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -69.08% | -72.76% | -51.62% | 157.69% | 243.23% |
| Foreign Exchange rate Adjustments | -845.45% | -422.22% | -228.57% | -300.00% | -650.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 118.52% | 81.45% | 205.84% | 326.26% | -200.20% |